Suppressive Effect of Fraxetin on Adipogenesis and Reactive Oxygen Species Production in 3T3-L1 Cells by Regulating MAPK Signaling Pathways
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Woonghee | - |
dc.contributor.author | Song, Gwonhwa | - |
dc.contributor.author | Bae, Hyocheol | - |
dc.date.accessioned | 2022-11-17T23:40:19Z | - |
dc.date.available | 2022-11-17T23:40:19Z | - |
dc.date.created | 2022-11-17 | - |
dc.date.issued | 2022-10 | - |
dc.identifier.issn | 2076-3921 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/145690 | - |
dc.description.abstract | Recent studies have identified obesity as one of the world's most serious chronic disorders. Adipogenesis, in which preadipocytes are differentiated into mature adipocytes, has a decisive role in establishing the number of adipocytes and determining the lipid storage capacity of adipose tissue and fat mass in adults. Fat accumulation in obesity is implicated with elevated oxidative stress in adipocytes induced by reactive oxygen species (ROS). Adipogenesis regulation by inhibiting adipogenic differentiation and ROS production has been selected as the strategy to treat obesity. The conventional anti-obesity drugs allowed by the U.S. Food and Drug Administration have severe adverse effects. Therefore, various natural products have been developed as a solution for obesity, suppressing adipogenic differentiation. Fraxetin is a major component extracted from the stem barks of Fraxinus rhynchophylla, with various bioactivities, including anti-inflammatory, anticancer, antioxidant, and antibacterial functions. However, the effect of fraxetin on adipogenesis is still not clearly understood. We studied the pharmacological functions of fraxetin in suppressing lipid accumulation and its underlying molecular mechanisms involving 3T3-L1 preadipocytes. Moreover, increased ROS production induced by a mixture of insulin, dexamethasone, and 3-isobutylmethylxanthine (MDI) in 3T3-L1 was attenuated by fraxetin during adipogenesis. These effects were regulated by mitogen-activated protein kinase (MAPK) signaling pathways. Therefore, our findings imply that fraxetin possesses inhibitory roles in adipogenesis and can be a potential anti-obesity drug. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.subject | ADIPOCYTE DIFFERENTIATION | - |
dc.subject | LIPID-ACCUMULATION | - |
dc.subject | OXIDATIVE STRESS | - |
dc.subject | GENE PROMOTER | - |
dc.subject | OBESITY | - |
dc.subject | KINASE | - |
dc.subject | INHIBITION | - |
dc.subject | ACTIVATION | - |
dc.subject | EXPRESSION | - |
dc.subject | ORLISTAT | - |
dc.title | Suppressive Effect of Fraxetin on Adipogenesis and Reactive Oxygen Species Production in 3T3-L1 Cells by Regulating MAPK Signaling Pathways | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Song, Gwonhwa | - |
dc.identifier.doi | 10.3390/antiox11101893 | - |
dc.identifier.scopusid | 2-s2.0-85140444599 | - |
dc.identifier.wosid | 000874144900001 | - |
dc.identifier.bibliographicCitation | ANTIOXIDANTS, v.11, no.10 | - |
dc.relation.isPartOf | ANTIOXIDANTS | - |
dc.citation.title | ANTIOXIDANTS | - |
dc.citation.volume | 11 | - |
dc.citation.number | 10 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Food Science & Technology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Food Science & Technology | - |
dc.subject.keywordPlus | ADIPOCYTE DIFFERENTIATION | - |
dc.subject.keywordPlus | LIPID-ACCUMULATION | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | GENE PROMOTER | - |
dc.subject.keywordPlus | OBESITY | - |
dc.subject.keywordPlus | KINASE | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | ORLISTAT | - |
dc.subject.keywordAuthor | fraxetin | - |
dc.subject.keywordAuthor | obesity | - |
dc.subject.keywordAuthor | adipogenesis | - |
dc.subject.keywordAuthor | mitogen-activated protein kinase | - |
dc.subject.keywordAuthor | ROS | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.